For the quarter ending 2025-09-30, DCGO had -$30,947,400 decrease in cash & cash equivalents over the period. $782,559 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -29,657,362 | -24,369,193 |
| Depreciation of property and equipment | 1,249,968 | 2,432,577 |
| Amortization of intangible assets | 1,448,548 | 2,751,441 |
| Amortization of finance lease right-of-use assets | 1,272,716 | 2,558,381 |
| Loss (gain) on disposal of fixed assets | -10,453 | -33,215 |
| Deferred income tax | -13,510,442 | -8,806,213 |
| Accretion of discount related to restricted investments | 69,486 | 145,403 |
| Loss on equity method investments | -27,035 | -79,515 |
| Bad debt expense | 1,214,666 | 2,492,009 |
| Stock-based compensation | 4,649,675 | 9,656,445 |
| Loss on remeasurement of operating and finance leases | 5,077 | -47,444 |
| Finite-lived intangible asset impairment | 8,020,343 | - |
| Goodwill impairment | 8,718,398 | - |
| Loss on change in fair value of contingent consideration | 1,052,394 | 0 |
| Accounts receivable | -14,528,162 | -86,194,306 |
| Prepaid expenses and other current assets | 129,747 | 5,273,060 |
| Other assets | -55,463 | -970,612 |
| Accounts payable | -2,074,591 | -18,246,793 |
| Accrued liabilities | 4,780,386 | -7,451,661 |
| Operating lease liabilities and right-of-use assets | 77,234 | 336,596 |
| Net cash provided by operating activities | 1,658,736 | 43,260,218 |
| Purchase of property and equipment | 876,177 | 2,170,883 |
| Acquisition of intangibles | 681,396 | 1,578,173 |
| Acquisition of a business, net of cash acquired | 0 | 3,646,318 |
| Purchase of restricted investments | 2,517,699 | 22,221,437 |
| Purchase of equity method investments | 4,784 | 0 |
| Proceeds from sale and maturity of restricted investments | 5,158,673 | 2,329,246 |
| Proceeds from disposal of property and equipment | 20,838 | 177,329 |
| Net cash used in investing activities | 1,099,455 | -27,110,236 |
| Proceeds from revolving credit line | 0 | 0 |
| Repayments of revolving credit line | 30,000,000 | 0 |
| Proceeds from notes payable | 258,700 | - |
| Repayments of notes payable | 20,903 | 6,258 |
| Due to seller | 106,943 | 750,919 |
| Acquisition of noncontrolling interest | 0 | - |
| Earnout payments on contingent liabilities | 1,687,134 | 265,538 |
| Distributions paid to noncontrolling interest | 175,831 | 0 |
| Proceeds from exercise of stock options | 0 | 0 |
| Payments for taxes related to shares withheld for employee taxes | 62,547 | 1,340,552 |
| Common stock repurchased | 0 | 10,828,906 |
| Payments on obligations under finance lease | 1,256,945 | 2,708,673 |
| Net cash used in financing activities | -33,051,603 | -15,900,846 |
| Effect of exchange rate changes on cash and cash equivalents | -653,988 | 968,129 |
| Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents | -30,947,400 | 1,217,265 |
| Cash and cash equivalents at beginning of period | 107,337,307 | - |
| Cash and cash equivalents at end of period | 77,607,172 | - |
DocGo Inc. (DCGO)
DocGo Inc. (DCGO)